Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
32.28
-1.49 (-4.41%)
At close: Mar 3, 2026, 4:00 PM EST
33.46
+1.18 (3.66%)
Pre-market: Mar 4, 2026, 8:44 AM EST

Teva Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
37,59535,88624,97111,70310,1328,835
Market Cap Growth
104.04%43.71%113.37%15.50%14.68%-16.46%
Enterprise Value
51,26949,42840,09729,25029,68631,095
Last Close Price
32.2831.2122.0410.449.128.01
PE Ratio
26.6825.79-15.20-20.88-4.1521.08
Forward PE
12.0312.078.354.213.633.02
PEG Ratio
10.701.826.690.401.630.68
PS Ratio
2.182.081.510.740.680.56
PB Ratio
4.694.544.651.561.300.86
P/TBV Ratio
4.754.594.641.561.300.86
P/FCF Ratio
32.7531.2633.3413.909.7237.44
P/OCF Ratio
22.8021.7620.038.566.3711.07
EV/Sales Ratio
2.972.862.421.851.991.96
EV/EBITDA Ratio
10.3515.6553.0418.44-33.3910.21
EV/EBIT Ratio
12.9722.92-132.3367.55-13.5118.12
EV/FCF Ratio
44.6643.0653.5334.7428.49131.76
Debt / Equity Ratio
2.162.163.162.482.512.09
Debt / EBITDA Ratio
5.415.4123.9112.71-24.257.70
Debt / FCF Ratio
14.8914.8924.1423.9420.6999.40
Net Debt / Equity Ratio
1.711.712.752.262.402.07
Net Debt / EBITDA Ratio
4.294.2919.5510.67-21.106.99
Net Debt / FCF Ratio
11.7911.7919.7320.1018.0090.23
Asset Turnover
0.430.430.400.360.330.32
Inventory Turnover
2.692.692.412.092.082.02
Quick Ratio
0.540.540.500.540.570.61
Current Ratio
1.041.040.981.021.051.14
Return on Equity (ROE)
20.80%20.80%-28.30%-7.36%-25.19%4.09%
Return on Assets (ROA)
6.18%6.18%-1.12%0.98%-3.82%2.37%
Return on Invested Capital (ROIC)
8.03%8.03%-1.43%1.21%-4.51%2.73%
Return on Capital Employed (ROCE)
8.02%8.02%-1.05%1.36%-6.35%4.63%
Earnings Yield
3.75%3.88%-6.58%-4.79%-24.12%4.74%
FCF Yield
3.05%3.20%3.00%7.19%10.28%2.67%
Updated Jan 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q